Cardiovascular Systems inks partnerships with OrbusNeich, Integer

Cardiovascular Systems (Nasdaq: CSII) announced today that it is expanding its product portfolio through new partnerships with OrbusNeich and Integer. The OrbusNeich partnership makes St. Paul, Minn.–based CSI the exclusive U.S. distributor of Hong Kong–based OrbusNeich‘s balloon products. The deal with Frisco, Texas–based Integer (NYSE: ITGR) involves Integer producing CSI-branded Zilient guidewires. Cardiovascular Systems CEO

Secant Group officials think they’ve cracked vascular regeneration: Here’s how

Secant Group today announced what it described as game-changing technology to advance vascular regeneration, solving problems that surgeons presently have when it comes to vascular harvesting and the non-resorbable synthetic graft compliance mismatching. The technology, which Secant (Telford, Pa.) developed in partnership with its sister company SanaVita Medical, involves a synthetic small bore vessel with a hollow

CES 2018: Medical technologies you need to know

Updated Jan. 16, 2018 Mobile health devices and wearables have increasingly played a prominent role at the annual CES show in Las Vegas. Health and medical devices touted at CES 2018 sought to improve everything from heart health to posture. Here are 13 companies that exhibited digital health solutions at this year’s show. Next >>

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

How startup Nanowear partnered with Secant: It took a year and a lot of meetings

Nanowear, which creates cloth-based diagnostic monitoring nanosensor technology, has entered into an exclusive, worldwide supply-chain partnership agreement with The Secant Group for scaled manufacturing and production of its medical-grade cloth-based nanosensor technology. Under the agreement, Nanowear and The Secant Group will have the collective obligation for marketing the technology and associated products. Nanowear received FDA 510(k) clearance for its remote congestive heart

Teleflex Medical launches new suture technology to reduce tissue strangulation

Teleflex Medical has created a new suture technology that may reduce tissue strangulation and a cutting effect in situations where tissue pull-through is a risk. The technology, called Force Fiber Fusion, is a two-in-one construct that goes from a round suture to a flat braid center segment and back to round suture. It is made

Bringing medical device manufacturing back to the U.S.: Here’s how it’s done

Here’s an inside look at one organization’s decision to bring medical device manufacturing back onshore. John Thomas, Bonifacio Consulting Services Deciding where and how to manufacture a product is without a doubt one of the most important decisions a medical device OEM faces. This decision has many implications, from the overall successful manufacture of the product

Medical device companies: These 15 performed the best in 2017

Updated Jan. 5, 2018 Among the most successful medical device companies of 2017, there were two themes: innovation and breadth of services. That was the major takeaway of an MDO analysis of the stock performance of the 100 largest publicly traded medtech companies in the world. What does innovation mean? Think Align Technology (Nasdaq:ALGN) and

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Stroke treatment: There’s a simple way to improve it in the U.S.

Technology is already available to greatly improve outcomes for people suffering from strokes, but the present healthcare system is standing in the way of people getting it, according to Stacey Pugh, VP and general manager of the neurovascular unit at Medtronic. The most important thing that could boost stroke treatment is passing proper legislation about

Zimmer Biomet wins FDA nod for Sidus stem-free shoulder system

Zimmer Biomet (NYSE:ZBH) said today it won FDA clearance for its Sidus stem-free shoulder system. The newly cleared Sidus system is designed as a total shoulder arthroplasty solution for patients with good bone stock with either osteoarthritis, post-traumatic arthrosis, focal avascular necrosis of the humeral head or those who’ve had previous surgeries of the shoulder that […]

Medtech stories we missed this week: Dec. 29, 2017

From NanoVibronix’s new Indian regulatory and distribution agreement to Guided Therapeutics’s Turkish distribution deal, here are five medtech stories we missed this week but thought were still worth mentioning. 1. NanoVibronix inks deal with Indian regulatory and distribution consultant NanoVibronix announced in a Dec. 20 press release that it has signed Morulaa HealthTech as its regulatory

7 top stories that mattered for medtech in 2017

The medtech industry saw its transformation accelerate in 2017: Whether it’s the roster of largest companies, business models or the regulatory environment, times are a-changing. Competition is also heating up in areas including diabetes care and robotic surgery. Here are seven stories that mattered for the medical device industry this year. Next>>

Pages: 1 2 3 4 5 6 7 8

Medtech stories we missed this week: Dec. 22, 2017

From Hepa Wash’s new collaboration to Stimwave’s FDA clearance, here are five medtech stories we missed this week but thought were still worth mentioning. 1. Hepa Wash collaborates with GALS program Hepa Wash announced in a Dec. 7 press release that it has collaborated with the German Accelerator Life Sciences (GALS) program to expand its

This procedure repairs joint damage and avoids hip replacement surgery

The Ohio State Wexner Medical Center is using a new procedure to help patients avoid hip replacement surgery while still repairing their hip. The procedure, called Subchondroplasty, involves injected a bone substitute material into the hip joint. The material helps fill voids or lesions in the joint. “We want to preserve the native hip whenever

How blocking an immune system response could improve heart attack survival

California researchers have discovered that the immune system’s response after a heart attack plays a significant role in what happens following a heart attack. Following a heart attack, heart cells begin to die, causing the immune system to send immune cells into the dead tissue to clear debris and start stabilizing the heart wall. University

These artificial heart muscle patches can repair dead heart muscles

A team of biomedical engineers have developed a fully functioning artificial human heart muscle that can be used as a patch to repair dead heart muscle. Duke University biomedical engineers developed the patch to be used in human patients who have previously suffered a heart attack. “Right now, virtually all existing therapies are aimed at